Encorafenib plus Binimetinib in Patients with locally advanced, inoperable, or metastatic BRAFV600 mutated Melanoma: First Data from the multicenter, multinational, prospective, non-interventional Longitudinal Study BERINGMELANOM

E Richtig, Dirk Debus, R Stadler, C Holler, JS Utikal, R Dummer, S Haferkamp, R von Moos, O Michielin, D Schadendorf

Research output: Contribution to journalAbstract (Journal)peer-review

Original languageGerman
Pages (from-to)81-82
JournalJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
Volume18
Publication statusPublished - 2020

Cite this